Cargando…
Neutropenia in patients under treatment with clozapine and COVID-19 infection
INTRODUCTION: Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. Case series report that clozapine-treated patients with COVID-19 have no documented neutropenia. OBJECTIVES: We sought to investigate the...
Autores principales: | Bonaccorso, S., Ricciardi, A., Ouabbou, S., Theleritis, C., Ross-Michaelides, A., Metastasio, A., Stewart, N., Mohammed, M., Schifano, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470401/ http://dx.doi.org/10.1192/j.eurpsy.2021.1796 |
Ejemplares similares
-
Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report
por: Bonaccorso, Stefania, et al.
Publicado: (2021) -
Increased violence and aggression levels during the SARS-Cov-2 pandemic; data from three London acute psychiatric inpatient facilities.
por: Bonaccorso, S., et al.
Publicado: (2023) -
Neutropenia in patients treated with clozapine during COVID-19 infection
por: Bonany, J. Marti, et al.
Publicado: (2021) -
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues
por: Bonaccorso, Stefania, et al.
Publicado: (2018) -
Successful clozapine rechallenge after neutropenia using lithium carbonate : a case report
por: Khattech, D., et al.
Publicado: (2022)